Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Praxis Precision Medicines, Inc.
(PRAX)
NASDAQ
:PRAX
PRAX
Praxis Precision Medicines
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Praxis Precision Medicines (PRAX) Stock News & Sentiment
Compare
Follow
908
Followers
Premium
Company Announcements
Praxis Precision Medicines Announces Major Underwritten Equity Offering
1d ago
8K
PRAX
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today, 12/31/2025, According to Top Analysts
9d ago
DRUG
PENG
Premium
Ratings
Compelling Risk‑Reward in Praxis Precision Medicines: Breakthrough Ulixacaltamide, Platform Upside, and $340 Target Price Support Buy Rating
10d ago
PRAX
Premium
Ratings
Praxis Precision Medicines: Breakthrough Neurology Pipeline and Regulatory Momentum Support Upside and Buy Rating
11d ago
PRAX
Premium
Company Announcements
Praxis Wins FDA Breakthrough Status for Ulixacaltamide
11d ago
8K
PRAX
Premium
Ratings
Praxis Precision Medicines: Ulixacaltamide’s Commercial Edge and 2026 Pipeline Catalysts Drive Substantial Upside to $843 Target
11d ago
PRAX
Premium
Company Announcements
Praxis Precision Medicines Plans New Drug Application
28d ago
8K
PRAX
More PRAX News >
PRAX News on the Web
All News
Bearish News
Bullish News
2026-01-07
Praxis Precision Medicines Prices $575 Million Public Offering at $260 Per Share—What Does This Mean for Its Future?
Market Chameleon
Neutral
2026-01-07
Praxis Precision Prices $575 Mln Public Offering At $260/shr
rttnews
Neutral
2026-01-01
Praxis Precision Medicines (PRAX) Gets a Buy from Chardan Capital
TipRanks News
Neutral
2025-12-30
Why Praxis Precision Medicines Stock Popped Today
The Motley Fool
Bullish
2025-12-30
Why Praxis Precision Medicines, Inc.’s (PRAX) Stock Is Down 5.22%
AAII
Neutral
2025-12-29
Breakthrough designation gives Praxis 'notable FDA validation,' says Jefferies
The Fly
Neutral
2025-12-29
Praxis Precision Medicines Wins FDA Breakthrough Designation For Essential Tremor Drug
rttnews
Neutral
2025-12-29
Stocks making the biggest moves premarket: DigitalBridge, Praxis Precision Medicines, Coupang & more
CNBC
Neutral
112
Results | Showing
1
out of
14
News Score - Last 7 Days
Neutral
PRAX
Sector Average
Media Buzz
This Week
2 articles
Weekly Average
3.5 articles
News Sentiment
This Week
59%
Sector Average
56%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is PRAX’s Media Buzz Sentiment?
2 articles about PRAX were published this week. In an average week, 3.5 articles are published.
What is PRAX’s weekly average amount of articles?
In an average week, 3.5 articles about PRAX are published.
What is PRAX’s News Sentiment?
59% of articles about PRAX were positive this week, compared to its sector average of 56%.
Healthcare Stocks that are Trending in the News
GNPX
Genprex
ARDX
Ardelyx
RIGL
Rigel
MRKR
Marker Therapeutics
TIL
Instil Bio
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.